Hospitals need to get ahead of regulations on climate change

St.ClaireRegionalMedicalCenterinMorehead,Ky.TheU.S.healthcaredeliverysystemaccountsforabout8.5%ofall AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli




fashion

author：knowledge    Page View：43
Dozens of sickle cells in a whirlpool — coverage from STAT
Adobe

Nearly a decade ago, consultants delivered to Rodger Novak a kind of Sears catalog of human malady: 200 pages, listing dozens of different diseases, each annotated with — from a business standpoint — their best and worst attributes. 

The document was supposed to help Novak, then the chief executive of CRISPR Therapeutics, navigate a pressing quandary. His company, along with two others, were founded to commercialize the new revolutionary gene-editing tool CRISPR-Cas9, which promised to cure numerous genetic diseases. But which should they target first? What was the best proof-of-concept?

advertisement

“We looked at anything and everything,” said Novak, who stepped down as CEO in 2017 but remained on the board until this year. 

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In
Previous article： Hospitals need to get ahead of regulations on climate change
Next article： Affirmative action in medical school literally saved lives